Free Trial

Flora Growth Q2 2024 Earnings Report

Flora Growth logo
$0.70 -0.02 (-2.80%)
As of 04:00 PM Eastern

Flora Growth EPS Results

Actual EPS
-$0.22
Consensus EPS
-$0.05
Beat/Miss
Missed by -$0.17
One Year Ago EPS
N/A

Flora Growth Revenue Results

Actual Revenue
$15.68 million
Expected Revenue
$20.74 million
Beat/Miss
Missed by -$5.06 million
YoY Revenue Growth
N/A

Flora Growth Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Flora Growth Earnings Headlines

Flora Growth files to sell 3.21M common shares for holders
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…
Flora Growth Raises $3.6 Million in Stock Offering
See More Flora Growth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Flora Growth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Flora Growth and other key companies, straight to your email.

About Flora Growth

Flora Growth (NASDAQ:FLGC), together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

View Flora Growth Profile

More Earnings Resources from MarketBeat